Table 2.
Pathological parameters of multiclonal biopsies as supported by discordant ERG/SPINK1 IHC (n=24)
| Gleason Score | n (%) |
| 6 | 13 (54%) |
| 3+4 | 5(21%) |
| 4+3 | 4 (17%) |
| >7 | 2 (12%) |
| Maximum Tumor Involvement % | |
| Median (range) | 78% (20%–100%) |
| <50% Involvement, n (%) | 2 (8%) |
| ≥50% Involvement, n (%) | 22 (92%) |
| Discordant IHC pattern | n (%) |
| ERG+/SPINK1− and ERG−/SPINK1− | 14 (58%) |
| ERG−/SPINK1+ and ERG−/SPINK1− | 7 (29%) |
| ERG+/SPINK1− and ERG−/SPINK1− | 3 (13%) |
Pathological parameters for the 24 (25%) multiclonal discontinuously involved prostate biopsy cores (of 97 assessed) as determined by discordant dual ERG/SPINK1 immunohistochemistry (IHC). Gleason score, maximum % tumor involvement (inclusive of intervening benign tissue) and ERG/SPINK1 status of the two discordant foci are provided for each core.